Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.
Jun 2010 - Am. J. Respir. Crit. Care Med.; 181(12):1535-4970 [PMID:20167848]
[Hegmans JP] [Veltman JD] [Lambers ME] [de Vries IJ] [Figdor CG] [Hendriks RW] [Hoogsteden HC] [Lambrecht BN] [Aerts JG]

Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.
Mai 2005 - Am. J. Respir. Crit. Care Med.; 171(10):1073-449X [PMID:15764728]
[Hegmans JP] [Hemmes A] [Aerts JG] [Hoogsteden HC] [Lambrecht BN]